Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis

Treatment of adults with newly diagnosed glioblastoma multiforme or anaplastic astrocytoma with surgery, gliadel wafers and limited field radiation plus concomitant temozolomide followed by adjuvant temozolomide

(2017) T. Ryken et al.   JOURNAL OF CLINICAL ONCOLOGY

Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas

(2009) Florence Lefranc   ACTA NEUROCHIRURGICA

From Randomized Controlled Trials to Observational Studies

(2009) Stuart L. Silverman   AMERICAN JOURNAL OF MEDICINE

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

(2009) Mary Lou Affronti et al.   CANCER

Localized BCNU chemotherapy and the multimodal management of malignant glioma

(2009) Renato V. La Rocca et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Neuroimaging in neuro-oncology

(2009) Soonmee Cha   Neurotherapeutics

The Importance of Tumor Volume in the Prognosis of Patients with Glioblastoma

(2009) Georgios Iliadis et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

(2008) Frank J. Attenello et al.   ANNALS OF SURGICAL ONCOLOGY

‘Recurrent’ glioblastoma multiforme, when should we reoperate?

(2008) Giuseppe M. V. Barbagallo et al.   BRITISH JOURNAL OF NEUROSURGERY

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

(2008) Steven H Lin et al.   Expert Review of Anticancer Therapy

MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

(2008) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients

(2008) Uwe Pichlmeier et al.   NEURO-ONCOLOGY

GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME

(2008) Nader Sanai et al.   NEUROSURGERY

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

(2007) Thierry Gorlia et al.   LANCET ONCOLOGY